Question explored with the scientific record
Is flu shot for seniors ok
The short version: for a healthy 70-year-old the flu shot is a reasonable bet; for a frail 85-year-old with dementia the evidence is much weaker than the schedule implies.
The real risk is not the flu itself for most seniors, it is pneumonia and heart events that follow it. In China, adults 65 and older carried an all-cause influenza death rate of about 123 per 100,000, versus about 3 per 100,000 under 65 [1]. That is the case for vaccinating. The case against overclaiming is that the best evidence for the shot in seniors is observational, and when you correct for bias the protection shrinks.
A 2014 meta-analysis of 14 cohort studies found the shot cut pneumonia hospitalizations and all-cause deaths in community-dwelling elderly, but the bias-adjusted numbers were weaker, and protection against lab-confirmed flu and flu-like illness lost significance [2]. That is the honest picture: some benefit against severe outcomes, thin evidence against infection itself. A 2025 study of 2,052 people aged 80+ with dementia found the unvaccinated had the most pneumonia, but vaccination did not significantly change hospitalization [3]. A 2026 cohort of frail elders found the flu shot alone showed no significant protection against pneumonia hospitalization or death; only combined with the pneumococcal vaccine did hospitalizations drop 35% [4].
| Group | Outcome | Result |
|---|---|---|
| 65+ (China) | Flu death rate | ~123 per 100,000 [1] |
| Community elderly | Pneumonia hospitalization, bias-adjusted | OR 0.75 [2] |
| Community elderly | All-cause death, bias-adjusted | OR 0.64 [2] |
| 80+ with dementia | Hospitalization | No significant change [3] |
| Frail elders, flu alone | Pneumonia hospitalization | No significant effect [4] |
| Frail elders, flu + pneumococcal | Pneumonia hospitalization | 35% reduction [4] |
The safety data is passive surveillance, which detects little by design. One Italian program tracked about 1,000 doses a season and found low reporting rates [7], and a Finnish program of 939 people found no serious reactions [8]. Neither is a powered safety trial. The clearest documented harm is Guillain-Barré syndrome, a nerve disorder: the 1976 swine flu vaccine raised risk roughly 4 to 7.6 times, and 1992-94 vaccines showed a small elevation of about 1 extra case per million doses [5]. Later seasons did not show it [6].
My call: for a community-dwelling senior with heart or lung disease, the shot is worth taking, because the pneumonia and death signal is real even after bias correction [2]. For a frail 85-year-old with dementia, the benefit is unproven and the decision is genuinely theirs [3][4]. Confidence: moderate for the healthy senior, low for the frail very old.
Sources used 8
-
Influenza-associated disease burden in mainland China: a systematic review and meta-analysis
An evidence synthesis and meta-analysis estimating influenza-associated mortality, hospitalization, and outpatient burden in mainland China from 2005–2019, highlighting the highest burden among adults ≥65 and children <5 and assessing sources of heterogeneity to inform vaccinati…
DOI: 10.1038/s41598-021-82161-z -
After adjusting for bias in meta-analysis seasonal influenza vaccine remains effective in community-dwelling elderly
A methodological meta-analysis comparing conventional and bias-adjusted approaches to estimating seasonal influenza vaccine effectiveness in community-dwelling elderly, showing that bias adjustment reduces heterogeneity and yields significant protection against hospitalization f…
DOI: 10.1016/j.jclinepi.2014.02.009 -
Association between influenza vaccine effectiveness and chronic diseases among older adults with dementia
This study investigates the effectiveness of influenza vaccination in reducing hospitalization rates, pneumonia incidence, and antibiotic use among older adults aged 80 and above with dementia, revealing that unvaccinated individuals had the highest incidence of pneumonia, while…
DOI: 10.1038/s41598-025-10633-7 -
Effectiveness of influenza and pneumococcal vaccination in frail older adults
In 12,268 frail older adults, combined influenza and pneumococcal vaccination was associated with a 35% reduction in pneumonia hospitalizations; single vaccines showed no significant protective association with pneumonia hospitalization or all-cause death.
DOI: 10.1590/1806-9282.20250884 -
Guillain-Barré Syndrome and Vaccination: Usually Unrelated
A narrative review of epidemiological data on Guillain-Barré syndrome (GBS) and vaccines concludes that GBS is usually triggered by antecedent infections rather than vaccination; clear causal associations were limited to the obsolete neural-tissue rabies vaccine and the 1976 swi…
DOI: 10.1177/001857870003500214 -
Assessing the risk of Guillain-Barré syndrome in older adults after bivalent RSV pre-F vaccination in England
A national vaccine-safety study in England found a small increased risk of Guillain-Barré syndrome after bivalent RSV pre-F vaccination in adults aged 74-79, with SCCS relative incidence 3.34 and about 23 attributable cases per million doses, outweighed by vaccine benefits.
DOI: 10.1038/s41467-025-66280-z -
Enhanced Passive Safety Surveillance (EPSS) confirms an optimal safety profile of the use of MF59 ® ‐adjuvanted influenza vaccine in older adults: Results from three consecutive seasons
In three consecutive Italian influenza seasons, passive enhanced safety surveillance of about 1,000 MF59-adjuvanted influenza vaccine (Fluad) doses per season in adults aged ≥65 years found low, seasonally stable spontaneous adverse event reporting rates (0.5%-0.7% ICSRs) consis…
DOI: 10.1111/irv.12685 -
Enhanced passive safety surveillance of the quadrivalent inactivated split-virion influenza vaccine (IIV4) in Finland during the 2019/20 influenza season
Enhanced passive safety surveillance of IIV4 in Finland in 2019/20 found no clinically significant change in suspected adverse drug reaction frequency or severity, with rates comparable to previous season and SmPC, supporting vaccine safety.
DOI: 10.1186/s12889-021-10378-8